Home › Peptides › GHRP-2

GHRP-2 dosage and protocol

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide that strongly stimulates GH secretion by activating the ghrelin receptor. It produces significant GH pulses and moderate appetite stimulation. Often stacked with CJC-1295 or MOD-GRF 1-29 for synergistic GH release. One of the most studied GHRPs with decades of research backing.

  • Vial size: 5 mg
  • Reconstitution: 3 mL bacteriostatic water
  • Concentration: 1.67 mg/mL
  • Administration: subcutaneous

Research areas

  • Growth Hormone
  • Appetite Increase
  • Muscle Growth
  • Recovery

Quick start

  • Reconstitute: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration
  • Typical daily range: 100–300 mcg once daily subcutaneously
  • Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U-100 syringe
  • Storage: Lyophilized at −20°C; after reconstitution, refrigerate at 2–8°C and use within 2–3 weeks

Dosing protocol

PhaseDoseFrequencyVolume
Weeks 1–2100 mcgOnce daily (SC)0.06 mL (6 units)
Weeks 3–4150 mcgOnce daily (SC)0.09 mL (9 units)
Weeks 5–16200 mcgOnce daily (SC)0.12 mL (12 units)

How it works

GHRP-2 (pralmorelin) is a synthetic hexapeptide that activates the growth hormone secretagogue receptor (GHS-R1a), the same receptor used by the stomach hormone ghrelin. Binding in the pituitary and hypothalamus triggers a pulse of growth hormone release, and the peptide also appears to blunt somatostatin, the brake on GH secretion. Because it works through a different pathway from GHRH, combining it with a GHRH analog such as CJC-1295 or Mod GRF 1-29 produces a larger GH pulse than either alone, a synergy documented in human pharmacology studies. The GH pulse raises downstream IGF-1 production by the liver, which mediates many of GH's effects on protein synthesis, lipolysis and tissue repair. GHRP-2 is less selective than ipamorelin: human studies show modest rises in cortisol (via ACTH) and prolactin, and it stimulates appetite through ghrelin-receptor signaling, though usually less than GHRP-6. GHRP-2 has been studied in humans for decades, mostly in short-term endocrine studies, and it has been used in Japan as a diagnostic agent for GH deficiency. Long-term outcome data on body composition, performance or aging in healthy people are lacking, and it is not approved for therapeutic use in the US.

Reconstitution steps

  • Draw 3.0mL bacteriostatic water with a sterile syringe
  • Inject slowly down the vial wall; avoid foaming
  • Gently swirl or roll until completely dissolved (do not shake)
  • Label and refrigerate at 2–8°C (35.6–46.4°F), protected from light

Storage

Store lyophilized at −20°C in dry, dark conditions. After reconstitution, refrigerate at 2–8°C and use within 2–3 weeks. Avoid repeated freeze–thaw cycles.

Important notes

  • Research use only
  • Increases appetite — ideal for bulking phases
  • Often used in conjunction with GHRH analogs like CJC-1295 for synergy
  • Possible water retention, increased appetite, cortisol or prolactin elevation with long-term use
  • Best combined with CJC-1295 or MOD-GRF 1-29 for synergistic effect
  • Take on empty stomach for best GH pulse response

Supplies

  • Bacteriostatic water
  • Insulin syringes
  • Alcohol swabs

Related peptides

Calculate your GHRP-2 dose in syringe units

Crestigen is an educational research reference. Nothing here is medical advice; many of these compounds are not approved for human use. Talk to a licensed clinician before using any substance.